Investor Presentation

September 2020

Forward-looking Statements and Non-GAAP Information

  • This presentation may include projections and other "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to future events and expectations and involve unknown risks and uncertainties. Omega's actual results or actions may differ materially from those projected in the forward-looking statements. For a summary of the specific risk factors that could cause results to differ materially from those expressed in the forward-looking statements, see Omega's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission.
  • This presentation may contain certain non-GAAP financial information including EBITDA, Adjusted EBITDA, Total Adjusted Debt (a/k/a, Funded Debt), Adjusted FFO, FAD, Total Cash Fixed Charges and certain related ratios. A reconciliation of these non-GAAP disclosures is available in the Exhibit to this presentation or on our website under "Non-GAAP Financial Measures" at www.omegahealthcare.com. Other financial information is also available on our website.
  • Information is provided as of June 30, 2020, unless specifically stated otherwise. We assume no duty to update or supplement the information provided.

Investor Presentation - September 2020

2

Omega Overview

Omega Overview: Key Credit Highlights

Financial Strength

Portfolio Strength

Experienced

Management

Team

  • Conservative leverage level with Funded Debt / Adj. Pro Forma EBITDA of 5.2x (2Q 2020) (1)
  • Consistent and stable free cash flow with strong fixed charge coverage of 4.2x (2Q 2020) (1)
  • Minimal secured borrowing; $9.8 billion+ of unencumbered real estate assets
  • Minimal short-term debt maturities
  • A history of rating agency upgrades and a commitment to an investment grade profile
  • Significant liquidity with ~$981 million of cash and credit facility availability at 8/31/2020
  • Strong core portfolio TTM rent coverage of 1.68x (EBITDARM) and 1.32x (EBITDAR) at 3/31/2020 (pre-COVID-19 coverage)
  • Geographic and operator diversification with 69 operators across 40 states and the United Kingdom
  • No upcoming material lease expirations and no material lease renewal risk
  • Favorable near-term supply and demand outlook
  • Senior management team (CEO, COO, & CFO) with average tenure over 19 years
  • Proven ability to execute on strategies
  • Proven ability to handle troubled assets

1) See 2Q 2020 Supplemental for detailed calculation

Investor Presentation - September 2020

4

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

Omega Healthcare Investors Inc. published this content on 15 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 September 2020 13:14:03 UTC